Georgia's Lieutenant Governor is calling on Delta to reinstate its relationship with the NRA. The backlash coming after Delta alerted the NRA plans to end its contract for discounted rates. Think Progress Editor Judd Legum explains how corporate America is splitting with NRA amid pressure from groups in light of a mass shooting inside a Florida high school earlier this month.
Former NBA star Al Harrington is looking to become the next marijuana mogul. He is taking on this emerging market with the introduction of his own line of CBD products that will roll out this summer. Harrington explains how marijuana can impact the pro-sports arena.
Cronos Group started trading on the Nasdaq Tuesday. The vertically integrated company became the first marijuana company to join a major exchange in the United States.
Student loan borrowers have the ability to earn retirement funds pegged to their payments – and the company Summer might be bringing it to your workplace.
It might not be what investors want to hear… but bringing down inflation could mean interest rates stay higher for (even) longer. But it's not all downside.
President Joe Biden and Chinese President Xi Jinping have discussed Taiwan, artificial intelligence and security issues in a call meant to demonstrate a return to regular leader-to-leader dialogue between the two powers.
April is Earth month, and while the green revolution might feel far away, the founder of climate VC Siam Capital says it’s on it’s way, and, even better: it won't cost you more.
From snow in April to heatwaves in December, it’s hard to plan a trip in a climate change world. Startup Sensible Weather thinks weather-based travel reimbursements are the solution.
Between corporate debt and the widening gap between ‘the haves and the have nots,’ there are reasons to be cautious about the economy, even with interest rate cuts on their way.
If the A.I. hype hasn’t given you enough of a reason to be excited (and a little terrified), the CEO of Zapata AI says the next frontier is designing bridges or creating pharmaceutical drugs.
